PD-1 bispecific antibodies combine checkpoint blockade with CTLA-4 or VEGF targeting. Can one engineered molecule offer ...

Six ESMO Trials that Changed Cancer Treatment / cancer, Destiny-Breast03, Durvalumab, enfortumab vedotin pembrolizumab, ESMO, ...

Mapping and Activating Social Networks to Support Older Adults With Cancer - SIOG / cancer, International Society of ...

The event is supported by Agenus and Deciphera as Enhanced Partners, PharmaMar as a Foundational Partner, and the Sarcoma ...

First Patients Dosed in Servier’s Phase 2 EMBLEM-1 Cohort Evaluating Emiltatug Ledadotin for Adenoid Cystic Carcinoma / ACC, ...

Equity and Implementation in the Australian Cancer Plan / cancer, Cancer Australia, Dorothy Keefe, Karen Canfell, OncoDaily, ...

Next-generation CDK 4, CDK 2 and degrader strategies aim to overcome CDK4/6 resistance and reduce toxicity in HR+/HER2− ...

RASolve 308 tests zoldonrasib with pembrolizumab and platinum chemotherapy as first-line treatment for metastatic RAS G12D ...

Excited to Join Pfizer as Chief Oncology Medical Officer / Arif Kamal, cancer, Chris Boshoff, Jeff Legos, Karin Tollefson, ...

Meet the International Panelists at OncoDaily Grand Rounds at ESMO 2026: Bladder Cancer Edition / Astellas Pharma, bladder ...

An International Gathering for Cancer Research and Care / AIOM, cancer care, Cancer research, esmo 2026, ESMO 2028, ESMO ...

The KWF Exploration Call supports fundamental research into cancer development, progression and spread, alongside its ...